{"id":"NCT00969618","sponsor":"Eli Lilly and Company","briefTitle":"A Long Term Follow-Up Study for Asian Adult Patients With Attention Deficit Hyperactivity Disorder","officialTitle":"Long-Term, Open-Label Safety and Efficacy Study of Atomoxetine Hydrochloride in Adult Patients With Attention-Deficit/Hyperactivity Disorder (ADHD)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-11","primaryCompletion":"2012-01","completion":"2012-01","firstPosted":"2009-09-01","resultsPosted":"2012-12-12","lastUpdate":"2012-12-12"},"enrollment":211,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Attention Deficit Hyperactivity Disorder"],"interventions":[{"type":"DRUG","name":"Atomoxetine","otherNames":["LY139603","Strattera"]}],"arms":[{"label":"Atomoxetine","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to assess long-term safety and tolerability in adult patients who have completed a previous atomoxetine study.","primaryOutcome":{"measure":"Number of Participants With Adverse Events Leading to Discontinuation","timeFrame":"Baseline through 48 weeks","effectByArm":[{"arm":"Atomoxetine","deltaMin":29,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":5},"locations":{"siteCount":12,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":211},"commonTop":["Nausea","Nasopharyngitis","Headache","Thirst","Decreased appetite"]}}